Related Experiment Videos
Human cytomegalovirus induces JC virus DNA replication in human fibroblasts
R Heilbronn1, I Albrecht, S Stephan
1Deutsches Krebsforschungszentrum, Heidelberg, Germany.
Abstract:
JC virus, a human papovavirus, is the causative agent of the demyelinating brain disease progressive multifocal leucoencephalopathy (PML). PML is a rare but fatal disease which develops as a complication of severe immunosuppression. Latent JC virus is harbored by many asymptomatic carriers and is transiently reactivated from the latent state upon immunosuppression. JC virus has a very restricted host range, with human glial cells being the only tissue in which it can replicate at reasonable efficiency. Evidence that latent human cytomegalovirus is harbored in the kidney similar to latent JC virus led to the speculation that during episodes of impaired immunocompetence, cytomegalovirus might serve as helper virus for JC virus replication in otherwise nonpermissive cells. We show here that cytomegalovirus infection indeed leads to considerable JC virus DNA replication in cultured human fibroblasts that are nonpermissive for the replication of JC virus alone. Cytomegalovirus-mediated JC virus replication is dependent on the JC virus origin of replication and T antigen. Ganciclovir-induced inhibition of cytomegalovirus replication is associated with a concomitant inhibition of JC virus replication. These results suggest that reactivation of cytomegalovirus during episodes of immunosuppression might lead to activation of latent JC virus, which would enhance the probability of subsequent PML development. Ganciclovir-induced repression of both cytomegalovirus and JC virus replication may form the rational basis for the development of an approach toward treatment or prevention of PML.
Insights
Cytomegalovirus (CMV) infection enables JC virus replication in non-glial cells, potentially increasing progressive multifocal leukoencephalopathy (PML) risk. Ganciclovir inhibits both viruses, suggesting a treatment strategy for PML.
Area of Science:
- Virology
- Neuroscience
- Immunology
Background:
- JC virus (JCV) causes progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease in immunosuppressed individuals.
- JCV has a limited host range, primarily replicating in human glial cells.
- Latent JCV is reactivated by immunosuppression, and human cytomegalovirus (CMV) latency in kidneys suggests a potential helper role.
Purpose of the Study:
- To investigate if human cytomegalovirus (CMV) can act as a helper virus for JC virus (JCV) replication in non-permissive human fibroblasts.
- To determine the mechanism of CMV-mediated JCV replication and its susceptibility to antiviral treatment.
Main Methods:
- Cultured human fibroblasts were infected with JCV alone or with CMV.
- JCV DNA replication was quantified in the presence and absence of CMV.
- The role of the JCV origin of replication and T antigen was assessed.
- The effect of ganciclovir on both CMV and JCV replication was evaluated.
Main Results:
- CMV infection significantly enhanced JCV DNA replication in human fibroblasts, which are normally non-permissive for JCV.
- CMV-mediated JCV replication was dependent on the JCV origin of replication and T antigen.
- Ganciclovir, an inhibitor of CMV replication, also inhibited JCV replication.
Conclusions:
- CMV reactivation during immunosuppression may facilitate JCV activation, increasing PML risk.
- Ganciclovir's ability to inhibit both CMV and JCV replication offers a potential therapeutic strategy for PML prevention or treatment.